Entering text into the input field will update the search result below

Corbus Pharmaceuticals revenues up 26% in FY 2017

  • Corbus Pharmaceuticals (NASDAQ:CRBP) FY results: Revenues: $2.4M (+26.3%); Operating Loss: ($32.6M) (-63.0%); Net Loss: ($32.4M) (-62.0%); Loss Per Share: ($0.65) (-32.7%); Quick Assets: $62.5M.
  • No guidance given.
  • Shares are down 4% premarket on light volume.

Recommended For You

More Trending News

About CRBP Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CRBP--
Corbus Pharmaceuticals Holdings, Inc.